We highly appreciate your interest in working with Ypsomed to support medical research.

Following our commitment to “Making self-care simpler and easier“, we would be honored  to be your partner of choice in treating people with diabetes.

With our injection and infusion systems and related services, we help millions of people, most of them diabetics, to enjoy the best possible quality of life. To continue this mission and facilitate the process of turning concepts into solutions, Ypsomed invites medical researchers to submit study proposals, which are received, reviewed and given feedback by a dedicated Research Screening Committee. If your study proposal is accepted, Ypsomed may provide you with Ypsomed devices and/or financial support. The following are the types of research projects the committee reviews:

  • Non-Clinical/Pre-Clinical Studies (animal, in vitro or in silico studies)
  • Clinical Trials (Investigator-Initiated Trials (IITs) aim to test clinical hypotheses in human subjects)

Areas of Interest

Ypsomed encourages researchers to submit study proposals targeting the following priority areas:

  1. Automated-Insulin Delivery treatment including mylife YpsoPump, Orbit infusion sets, and mylife CamAPS controllers
  2. Insulin-dependent diabetes Type 1 and beyond (e.g. pregnancy, gestational diabetes, Type 2, cystic fibrosis-related diabetes, gastroparesis)
  3. Extended wear of infusion sets
  4. Real World Evidence. Analysis of retrospective databases, registries and data collections
  5. Artificial intelligence-based decision support systems for diabetes

However, applications outside these priority areas will still be considered.

Submit your research proposal

We invite you to submit an initial concept for review (synopsis) via the application form below. If the initial concept is approved by Ypsomed, a full study proposal (full protocol, detailed budget) will be requested. Initial concept proposals are reviewed on an on-going basis, and full proposals are reviewed quarterly.

The Research Screening Committee is composed of Ypsomed experts pursuing responsibilities within various departments of the company. The Research Screening Committee meets on a regular basis to review all incoming applications.

The application process is by nature competitive and due to the high volume of applications, we might not be able to support all projects. Only complete applications will be considered. If you have any questions regarding the process, or would like to speak to the investigator-initiated trials program team regarding your new or existing application, please contact us at research.request@ypsomed.com

Published mylife YpsoPump System Research

Title/Description Primary Investigator(s) Primary Test Product Link to PubMed Abstract
Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial De Bock, M. OpenAPS algorithm, study continuation phase with YpsoPump PMID: 36763345
Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes Cohen, N. automated insulin delivery system AndroidAPS PMID: 36788715
First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Freckmann, G. mylife YpsoPump PMID: 29998760
Prospective Study of Insulin Infusion Set Use for up to 7 Days: Early Replacement Reasons and Impact on Glycemic Control Freckmann, G. Orbit Infusion set PMID: 32167382

Published CamAPS Research

Title/Description Primary Investigator(s) Primary Test Product Link to PubMed Abstract
Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial Bally, L. CamAPS HX PMID: 35880252
Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial Hovorka, R. CamAPS HX PMID: 34349267
Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes Hovorka, R. CamAPS FX PMID: 35045227
Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study Hovorka, R. CamAPS FX PMID: 35359882
Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial Hovorka, R. (study chair) CamAPS FX PMID: 35272971